Who to call at PHC株式会社 バイオメディカ事業部, and when
Fundz watches for the moments PHC株式会社 バイオメディカ事業部 starts buying, and tells you who to reach.
- An alert the day PHC株式会社 バイオメディカ事業部 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PHC株式会社 バイオメディカ事業部, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PHC株式会社 バイオメディカ事業部. With Fundz connected, it knows.
LaunchPHC Corporation wins The Analytical Scientist's 2024 Innovation Award for its live cell metabolic analysis device, LiCellMo™.
JapanManufacturingBiotechnologyHealth CareMedicalMedical DeviceImage RecognitionProduct Description
PHC Corporation has announced that its live cell metabolic analysis device, LiCellMo™, has won The Analytical Scientist's 2024 Innovation Award. Launched in September in Japan and set to expand into the US, UK, EU, China, and parts of Asia, LiCellMo™ provides real-time visualization of cellular metabolic changes, enhancing research in cell gene therapy and drug development processes.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PHC株式会社 バイオメディカ事業部 ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Product Launch Insights
What this usually meansPHC株式会社 バイオメディカ事業部 shipped something new. Fundz reads product launches, trademark filings and hiring together.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.